163 related articles for article (PubMed ID: 31263218)
1. Preclinical rare cancer research to inform clinical trial design.
Barker HE; Scott CL
Nat Rev Cancer; 2019 Sep; 19(9):481-482. PubMed ID: 31263218
[No Abstract] [Full Text] [Related]
2. The promise and challenges of rare cancer research.
Komatsubara KM; Carvajal RD
Lancet Oncol; 2016 Feb; 17(2):136-138. PubMed ID: 26868336
[No Abstract] [Full Text] [Related]
3. Clinical Cancer Advances 2017: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology.
Burstein HJ; Krilov L; Aragon-Ching JB; Baxter NN; Chiorean EG; Chow WA; De Groot JF; Devine SM; DuBois SG; El-Deiry WS; Epstein AS; Heymach J; Jones JA; Mayer DK; Miksad RA; Pennell NA; Sabel MS; Schilsky RL; Schuchter LM; Tung N; Winkfield KM; Wirth LJ; Dizon DS
J Clin Oncol; 2017 Apr; 35(12):1341-1367. PubMed ID: 28148207
[No Abstract] [Full Text] [Related]
4. Cancer genomics and clinical practice: how can we close the gap more quickly?
Konecny GE
Curr Opin Obstet Gynecol; 2017 Feb; 29(1):1-3. PubMed ID: 27941363
[No Abstract] [Full Text] [Related]
5. Trials and tribulations: improving outcomes for adolescents and young adults with rare and low survival cancers.
Walczak A; Patterson P; Thomas D
Med J Aust; 2018 Oct; 209(8):330-332. PubMed ID: 30309304
[No Abstract] [Full Text] [Related]
6. Clinical Trials in the Evolving Landscape of Precision Medicine.
Cancer Cell; 2020 Jul; 38(1):3-8. PubMed ID: 32663468
[TBL] [Abstract][Full Text] [Related]
7. 2017 ASH Meeting.
Yaqub F
Lancet Oncol; 2018 Jan; 19(1):21. PubMed ID: 29249307
[No Abstract] [Full Text] [Related]
8. Rare cancers: the greatest inequality in cancer research and oncology treatment.
Alvi MA; Wilson RH; Salto-Tellez M
Br J Cancer; 2017 Oct; 117(9):1255-1257. PubMed ID: 28934760
[No Abstract] [Full Text] [Related]
9. Under-representation of older adults in cancer registration trials: known problem, little progress.
Scher KS; Hurria A
J Clin Oncol; 2012 Jun; 30(17):2036-8. PubMed ID: 22547597
[No Abstract] [Full Text] [Related]
10. Feasibility of a Centralized Clinical Trials Coverage Analysis: A Joint Initiative of the American Society of Clinical Oncology and the National Cancer Institute.
Szczepanek CM; Hurley P; Good MJ; Denicoff A; Willenberg K; Dawson C; Kurbegov D
J Oncol Pract; 2017 Jun; 13(6):395-400. PubMed ID: 28481681
[TBL] [Abstract][Full Text] [Related]
11. The New Frontiers in Cancer.
Batista A
Trends Cancer; 2016 Oct; 2(10):533. PubMed ID: 28741481
[No Abstract] [Full Text] [Related]
12. Clinical cancer research: the past, present and the future.
DeVita VT; Eggermont AM; Hellman S; Kerr DJ
Nat Rev Clin Oncol; 2014 Nov; 11(11):663-9. PubMed ID: 25245981
[TBL] [Abstract][Full Text] [Related]
13. Research methods to change clinical practice for patients with rare cancers.
Billingham L; Malottki K; Steven N
Lancet Oncol; 2016 Feb; 17(2):e70-e80. PubMed ID: 26868356
[TBL] [Abstract][Full Text] [Related]
14. Cancer research and clinical trial in action: an important exercise before you embark on your study.
Carbone L; Kurtzman SH; Leong SP
Cancer Treat Res; 2007; 132():291-309. PubMed ID: 17305029
[No Abstract] [Full Text] [Related]
15. Inside ASCO 2014.
Oncology (Williston Park); 2014 Jul; 28(7):643-8. PubMed ID: 25144289
[No Abstract] [Full Text] [Related]
16. Clinical Cancer Advances 2021: ASCO's Report on Progress Against Cancer.
Smith SM; Wachter K; Burris HA; Schilsky RL; George DJ; Peterson DE; Johnson ML; Markham MJ; Mileham KF; Beg MS; Bendell JC; Dreicer R; Keedy VL; Kimple RJ; Knoll MA; LoConte N; MacKay H; Meisel JL; Moynihan TJ; Mulrooney DA; Mulvey TM; Odenike O; Pennell NA; Reeder-Hayes K; Smith C; Sullivan RJ; Uzzo R
J Clin Oncol; 2021 Apr; 39(10):1165-1184. PubMed ID: 33527845
[No Abstract] [Full Text] [Related]
17. The National Clinical Trials Network: Conducting Successful Clinical Trials of New Therapies for Rare Cancers.
Schott AF; Welch JJ; Verschraegen CF; Kurzrock R
Semin Oncol; 2015 Oct; 42(5):731-9. PubMed ID: 26433554
[TBL] [Abstract][Full Text] [Related]
18. Cancer research in the United States: dying by a thousand paper cuts.
Kantarjian H; Stewart DJ; Zwelling L
Cancer; 2013 Nov; 119(21):3742-5. PubMed ID: 23744791
[No Abstract] [Full Text] [Related]
19. Revolutionizing Precision Oncology through Collaborative Proteogenomics and Data Sharing.
Rodriguez H; Pennington SR
Cell; 2018 Apr; 173(3):535-539. PubMed ID: 29677503
[TBL] [Abstract][Full Text] [Related]
20. Targeted therapies: cui prodest?
Ferrari D; Foa P
J Clin Oncol; 2007 Oct; 25(29):4691-2; author reply 4692. PubMed ID: 17925568
[No Abstract] [Full Text] [Related]
[Next] [New Search]
